A Novel Fibrinolysis Resistance Capacity Assay can Detect Fibrinolytic Phenotypes in Trauma Patients
Thrombosis and Haemostasis · 01.12.2025 · 125 (12) · 1205-1215
DOI: 10.1055/a-2508-3424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.12.2025. Verfasst von Christopher D Barrett und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Acute Care Surgery, Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, United States. Hauptthemen laut MEDLINE: Fibrinolysis, Fibrin Clot Lysis Time, Wounds and Injuries, Multiple Trauma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, JSPS KAKENHI, NIGMS NIH HHS.
Abstract (Originalsprache)
To evaluate residual fibrinolysis resistance activity (FRA) in plasma, a detergent-modified plasma clot lysis assay time (dPCLT) was established in which α2-antiplasmin (A2AP) and plasminogen activator inhibitor type 1 (PAI-1) are inactivated without impacting protease activity. We applied this novel assay to severely injured trauma patients’ plasma. Tissue-type plasminogen activator (tPA)-induced plasma clot lysis assays were conducted after detergents- (dPCLT) or vehicle- (sPCLT) treatment, and time to 50% clot lysis was measured (“transition midpoint”, T m). Residual FRA was then calculated as ([sPCLT T m] - [dPCLT T m]/[sPCLT T m]) x100% = Δ Tm PCLT (%). Assay results were compared to rapid thromboelastography (TEG) LY30, tPA TEG LY30, and plasma fibrinolysis biomarkers in polytrauma patients’ plasma (N=43). Δ Tm PCLT(%) in normal plasma (N=5) was 63.0 ± 8.3 whereas in A2AP-depleted plasma was -19.1 ± 1.3%, Plasmin-antiplasmin (PAP) complex increased after complete lysis of sPCLT, whereas that in dPCLT was negligible in normal plasma. In trauma plasma, significant correlations between Δ Tm PCLT and active PAI-1 (r = 0.85, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Acute Care Surgery, Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, United States.
- Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, United States.
- Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Surgery, Ernest E Moore Shock Trauma Center at Denver Health, Denver, Colorado, United States.
- Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.
- Division of Solid Organ Transplantation, Department of Surgery, AdventHealth Porter, Denver, Colorado, United States.
ORCID-Profile: Christopher D Barrett, Yuko Suzuki, Hunter B Moore, Tetsumei Urano
Förderung
- NHLBI NIH HHS
- JSPS KAKENHI
- NIGMS NIH HHS
- National Heart Lung and Blood Institute
- Japan Agency for Medical Research and Development
- National Institute of General Medical Sciences
Zitieren
APA
Barrett, C. D., Suzuki, Y., Moore, E. E., Moore, H. B., Maginot, E. R., White, C. M., Siddiqui, H., Gawargi, F. I., Chandler, J. G., Sauaia, A., & Urano, T. (2025). A Novel Fibrinolysis Resistance Capacity Assay can Detect Fibrinolytic Phenotypes in Trauma Patients. Thrombosis and Haemostasis, 125(12), 1205-1215. https://doi.org/10.1055/a-2508-3424
Vancouver
Barrett CD, Suzuki Y, Moore EE, Moore HB, Maginot ER, White CM, et al. A Novel Fibrinolysis Resistance Capacity Assay can Detect Fibrinolytic Phenotypes in Trauma Patients. Thrombosis and Haemostasis. 2025;125(12):1205-1215. doi:10.1055/a-2508-3424
BibTeX
@article{Barrett2025,
author = {Barrett, Christopher D and Suzuki, Yuko and Moore, Ernest E and Moore, Hunter B and Maginot, Elizabeth R and White, Collin M and Siddiqui, Halima and Gawargi, Flobater I and Chandler, James G and Sauaia, Angela and Urano, Tetsumei},
title = {A Novel Fibrinolysis Resistance Capacity Assay can Detect Fibrinolytic Phenotypes in Trauma Patients},
journal = {Thrombosis and Haemostasis},
year = {2025},
volume = {125},
number = {12},
pages = {1205--1215},
doi = {10.1055/a-2508-3424}
}
EUVIMED